NUCERITY INTERNATIONAL, INC. – Trademark Portfolio
Entity Type: 03
NUCERITY INTERNATIONAL, INC. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 19 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NUCERITY and CREATING BEAUTIFUL LIVES. The owner is based in HOUSTON, TX.
7880 SAN FELIPE
SUITE 200
HOUSTON, TX 77063
Showing of trademarks Trademarks
Trademark Classifications
NUCERITY INTERNATIONAL, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NUCERITY INTERNATIONAL, INC. have?
NUCERITY INTERNATIONAL, INC. has 22 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 abandoned, 14 cancelled.
What trademark classes does NUCERITY INTERNATIONAL, INC. file in?
NUCERITY INTERNATIONAL, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are NUCERITY INTERNATIONAL, INC.'s most well-known trademarks?
NUCERITY INTERNATIONAL, INC.'s registered trademark portfolio includes well-known marks such as NUCERITY and CREATING BEAUTIFUL LIVES. These are among 2 currently registered trademarks in the portfolio.
What is NUCERITY INTERNATIONAL, INC.'s trademark registration success rate?
NUCERITY INTERNATIONAL, INC. has a 9% trademark registration rate, with 2 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.